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ABSTRACT
The purpose of this study was to evaluate the immunocontraceptive
GonaCon™ in reducing fecundity in Eastern gray squirrel (EGS) (Sciurus
carolinensis) in urban areas. Using a modified box trap design, 317 EGS were
captured during four trapping sessions on a 5.66 ha site on Clemson
University’s main campus. EGS were handled using a restraint cone and
sexed, weighed, ear-tagged and implanted with a microchip at the nape of the
neck on all “original” captures and later identified in subsequent captures as
“recaptures.” Blood samples and morphometric data were obtained on EGS
before the immunocontraceptive GonaCon™ was administered by injection
during three trapping sessions to 33 EGS (17m, 16f) in trapping session 1
(TS1), 23 (14m, 9f) in trapping session 2 (TS2), and 11 (8m, 3f) in trapping
session 3 (TS3) at a dosage rate of 0.4 ml containing 400 µg of GnRH-blue
protein conjugate intramuscularly in the thigh. Control EGS were given a sham
injection containing 0.4 ml saline- AdjuVac™ during the three trapping
sessions: 22 EGS (16m, 6f) in TS1, 20 (12m, 8f) in TS2, and 8 (4m, 4f) in TS3.
In the last trapping session (TS4) 35 EGS were necropsied to evaluate
histological changes in testes and ovaries as potential metrics of GonaCon™
efficacy and to determine its potential side effects.
EGS density on the study area was estimated to be 9 ± (2.89) EGS/ha,
based on the Lincoln-Peterson model. There were no significant differences in
body weights of treated and control EGS by TS3 (p = 0.40), or testosterone (p
ii

= 0.32) and progesterone (p = 0.68) levels. However, there were significant
differences in antibody titers between treated and control EGS by TS3 in both
males and females active antibodies seen in the treatment group (χ2 = 5.656,
df = 1, p = 0.017). There were highly significant differences in scrotal size of
treated and control males with a reduction in scrotal size being observed in
treated males (t= 10.14, df = 8, p = 0.001). There were marked histological
changes in treated EGS males and no observable histological changes in
treated EGS females. Although there were no serious side effects to the
vaccine; 6 EGS developed injection site abscesses. GonaCon™ may be a
potential tool to manage EGS overabundance in urban areas, but additional
research is needed.
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CHAPTER ONE

IMMUNOCONTRACEPTION AS A TOOL TO MANAGE OVERABUNDANCE
OF WILDLIFE POPULATIONS
One of the many spin-offs of a burgeoning human population is the
shrinkage of wildlife habitats and the attendant overabundance of native species,
or the invasion of introduced exotic species. This in turn shapes human tolerance
of the presence and activities of free-ranging animals. The overabundances of
native species with its negative ecological implications, and the invasion of exotic
species with the consequent threat to native biota, are two faces of the same
coin (Garrott et al. 1993). The Eastern gray squirrel (Sciurus carolinensis) is a
prime example of both of these scenarios. This species not only thrives well in its
native range in the United States, but it is also considered invasive in England,
because it has displaced and almost taken over the range of the endemic red
squirrel (Sciurus vulgaris). The crux of the invasion process occurs in six stages:
introduction, establishment, naturalization, dispersal, population distribution, and
invasive spread (Henderson et al. 2006). In essence, overabundance can be
insidious, and such animals are often categorized as nuisance wildlife.
Inferences drawn from invasion biology (Davis 2009) can be applied to
overabundance:
•

Virtually all natural environments are prone to species invasion to some
degree;
1

•

The most reliable predictor of species invasion is resource availability, with
both temporal and spatial variation in resources shown to be the primary
mechanisms by which pools of resources are made available to incoming
species;

•

Enemy and facilitator-related processes can be important in accounting for
invasion in some instances, but neither has proven to be as reliable a
predictor of species invasion as resource availability;

•

Diversity has not been shown to be a reliable predictor of species invasion
under natural conditions at any spatial scale; and

•

The same processes affecting species invasion are driving diversity.
On another level, wildlife can be construed to be locally overabundant

when in fact they may be threatened or endangered. For example, there has
been an increase in the population densities of the African elephant (Loxodonta
africana) in many of its range countries due to the control of poaching and a ban
on ivory trade. As another example, the common leopard (Panthera pardus) has
taken refuge in tea gardens of Assam, India, and breeds rather well in this
alternate habitat. African elephants and leopards are both endangered, yet
overabundant in parts of Africa and India.
According to Caughley (1981), the criteria for overabundance of animals can
be based upon the degree in which they:
•

Threaten human life or livelihood,

•

Are too numerous for their “own good,”
2

•

Depress the densities of economically or aesthetically important species,
and

•

Cause ecosystem dysfunction.
The risk of zoonotic diseases such as avian influenza, rabies and

tuberculosis gets compounded in the event of species overabundance. The
influenza virus is now known to jump between 3 taxonomic groups: avian, human
and swine. The overabundance of all the 3, in part, has resulted in the ongoing
pandemic. The intra-specific spread of diseases among wildlife populations is no
less daunting, since many species in some areas exceed their carrying capacity
(K). Two-thirds of the one-horned rhinoceros (Rhinoceros unicornis) in the world
survive in the grasslands of Kaziranga in India; more than 2000 rhinos in only
430 km2 of the national park. The risk of having “all eggs in one basket” is
accentuated by overabundance. There is also a glut of many captive wildlife
species in zoos across the world, leading to constraints in housing and captive
breeding of endangered species.
Native and exotic species alike, can impact human health, national and
local economies, and ecosystems and ecosystem services (Davis 2009).
Ecosystem services are defined as the conditions and processes through which
natural ecosystems, and the species that make them up, sustain and fulfill
human life (Daily 1997). Overabundance of free-ranging wildlife populations
interferes with ecosystem services, and therefore is an important driver of human
wildlife conflicts. The newly emerged discipline of wildlife damage management
3

is primarily concerned with the challenges of controlling overabundant species
and their negative impacts. However, a diagnosis of wildlife overabundance can
only be made when placed in a specific context (McShea et al. 1997).
There are many examples where overabundant wildlife populations have
created conflicts with humans and other wildlife. For example, white-tailed deer
(Odocoileus virginanus), Canada geese (Branta canadensis), African elephants
(Loxodonta africana), and rhesus macaques (Macaca mulatta) have become
problem species on a community, and in some cases on a landscape scale. In
North America, white-tailed deer populations in some areas became
overabundant in the mid-seventies. Increasing suburbanization and concurrent
decreases in agricultural land use created large areas of predator-scarce habitat
(Diamond 1992, McCullough et al. 1997). In South Carolina, because of
expanding populations, white-tailed deer have been reported to cause an
estimated $52.4 million dollars in damage to agricultural production in one year
(Smathers et al. 1994). Conover (et al. 1995) reported an estimated 29,000
human injuries and 211 human fatalities each year as a result of 726,000 deervehicle accidents annually in the U.S. In 1991, there was a conservative
estimate of over 538,000 deer deaths in 36 states as a result of deer-vehicle
collisions (Lehnert and Bissonette 1997).
Overabundance of Canada geese is well documented in many areas of
the U.S., with geese- inflicted damage to grain and forage crops. In addition, the
presence of feeding geese on lawns, in parks, on golf courses and in backyards
4

has sparked ire among many residents of several U.S. cities (Conover and
Chasko 1985). In Ghana and Zimbabwe, the African elephant long afforded
protection from poaching and overexploitation, has created new conflicts.
Elephant densities have swelled to such an extent that they freely roam
communal lands, depredate crops and compete for scarce water resources
(Lamarque et al. 2005). India has an overabundance of rhesus macaques and
laws banning their export (Mandavalli 2006). This has led to high conflict levels in
urban areas in recent times. In Italy, gray squirrel (Sciurus carolinensis)
populations introduced to a broad-leaf forest patch in 1970, are now
overabundant and likely to spread throughout Europe and Asia (Bertolino and
Genovesi 2003).
Management programs that address conflicts caused by wildlife
overabundance have four parts that include 1) problem identification, 2) ecology
of the problem species, 3) application of control methods, and 4) evaluation of
control efforts (Dolbeer et al. 1994). Problem definition refers to determining the
species and numbers of wildlife causing a particular problem, the amount of loss
or nature of the conflict, and other biological and social factors related to the
problem. Understanding the ecology and life history of a species is important in
wildlife damage management, especially in context of understanding cause of
conflicts and potential solutions. Application of control methods utilizes an
understanding of the ecology of a particular species to develop an appropriate
management program to reduce conflict(s). Evaluation of control efforts helps to
5

assess the effectiveness of control methods in reducing or eliminating conflicts in
a safe, humane, cost-effective, and socially acceptable manner.
Traditional techniques that have been used to reduce negative impacts
associated with wildlife overabundance include 1) excluding problem wildlife, 2)
habitat modification, 3) frightening problem wildlife, 4) repelling problem wildlife,
5) live trapping and removal of problem wildlife, 6) lethal methods, or 7) a
combination of the above techniques (Hygnstrom et al. 1994).
Exclusion involves keeping problem wildlife out of an area using physical
barriers. Examples include woven wire fences, electric fences, or any other
barrier that prevents entry or access into an area that needs protection
(Hygnstrom et al. 1994). For example, physical barriers have been used by land
managers and conservation agencies in Australia to exclude feral cats (Felis
cattus), red fox (Vulpes vulpes) and European rabbits (Oryctolagus cuniculus)
(Moseby and Read 2006). All three species were introduced to Australia by
Europeans and have successfully colonized much of mainland Australia. Fences
are typically installed to reduce white-tailed deer damage in the U.S. and
materials may include wire or plastic mesh, electrified high-tensile steel wire, and
electrified polytape (VerCauteren et al. 2006)
Habitat modification as a means of reducing wildlife damage involves
removing habitat components (e.g. food, shelter, and water) to make areas less
desirable for problem wildlife species (Hygnstrom et al. 1994). For example,
Canada geese require open areas to feed and can be discouraged by
6

landscaping an area with trees, bushes, hedges, boulders, or anything that
geese would have difficulty seeing around. In addition, draining unwanted ponds
that are adjacent to open areas (e.g. lawns) has been effective in making areas
less inviting to geese (Conover 2002). In some cases, habitat modification may
include enhancing habitat components in areas to attract wildlife away from sites
that need protection. An example is planting food crops for white-tailed deer to
“lure” them away from ornamental plantings and gardens in residential areas
where they may cause damage.
Frightening can also be used to temporarily “scare” wildlife away from
areas to reduce potential conflicts. A variety of frightening devices are used to
move wildlife from local areas and include pyrotechnics, gas exploders, effigies,
lights, lasers, reflectors, guard animals, bioacoustics and ultrasonic devices
(Hygnstrom et al. 1994). These techniques are often more effective when used
in an integrated system that incorporates multiple stimuli (Gilsdorf et al. 2002).
A variety of repellents have been used to keep wildlife away from
protected areas. Repellents work by creating an aversion response based on
taste, touch or smell (Hygnstrom et al. 1994). There are two general categories
of repellents, primary and secondary. Primary repellents work with disruptive
stimuli and affect normal behaviors of an animal. Secondary repellents work with
aversive stimuli and affect occurrence of specific negative behaviors (Shivik et al.
2003). An example of a primary repellent is the use of predator odors, such as
red fox or raccoon (Procyon lotor) urine smeared on butternuts, which repels
7

gray squirrels (Rosell 2001). An example of secondary repellents is the use of
chili grease smeared on coir rope around the periphery of rice fields to deter
elephants by conditioned taste aversion (Sitati and Walpole 2006).
Live-trapping involves removing problem wildlife by trapping and
relocating to areas where conflicts are less likely to occur. There are pros and
cons in trapping and relocating problem wildlife. For example, relocation of
problem black bears (Ursus americanus) using culvert-traps to capture bears
was used in northeastern Oregon as an alternative to lethal removal of bears that
attacked sheep (Armistead et al. 1994). Although relocation costs did not differ
from that of killing depredating bears, the former method had better social
acceptance. Some state wildlife agencies (e.g. South Carolina), however, do not
allow live-trapping and relocation of wildlife, especially problem wildlife.
Concerns center around survivability of relocated wildlife, impacts of relocated
wildlife on other species, and the potential for disease transmission (Cunningham
1996).
The use of lethal methods to control populations of overabundant wildlife
involves killing animals by shooting, lethal traps, or poisoning. With game
species, populations are regulated through recreational hunting. Public
acceptance and stakeholder support of lethal methods to control wildlife
overabundance is not universally accepted in some areas across the world.
However, removal of some species using lethal means has a legitimate role in
wildlife conservation (Treves and Naughton-Treves 2005). A case in point is the
8

hunting of white-tailed deer in North America, which provides recreation for
sportsmen and revenue for conservation as well.
Several experimental approaches to address wildlife overabundance and
associated conflicts are currently being tested and evaluated, one of which is the
use of anti-fertility vaccines. The development of anti-fertility vaccines is an
offshoot of similar technologies used in the prevention of infectious diseases
(Tizard 2009). In one example, an antigen in the form of a protein, elicits an
immune response when administered to a healthy animal, leading to the
production of antibodies. This reaction is used to intercept critical steps in the
production and secretion of sex hormones such as estrogen and testosterone.
The net result is diminished reproduction or its cessation. This technology has
been in vogue for several years and has been tested on a variety of species with
varying success (Miller et al. 1998). Reversible sterilization of wildlife by holding
them in permanent care facilities has proven to be a good management option
for some species such as the African elephant and cheetah. However, the use of
anti-fertility vaccines on free-ranging animals is often complicated by legal,
biological, economic and ethical issues (Guynn 1993).
The goal of contraceptive vaccines can be categorized as either
immunocontraception or immunoneutering. Immunocontraceptive vaccines aim
to prevent fertilization of the oocyte by sperm or implantation of the fertilized egg
while retaining sexual behavior patterns and competition in mating.
Immunocontraception works on both sexes, but depending on the species, is
9

only used on one of the sexes. Immunocontraceptives (specifically GonaConTM )
prevent production and/or maturation of gametes. This approach has gained
acceptance by some for control of feral animal pests or native wildlife.
Immunoneutering vaccines aim to prevent all sexual behaviors in both male and
female animals, as well as control fertility. These outcomes are suitable for
companion animals, livestock, and in some instances feral animals perceived as
pests (Meeusen et al. 2007).
Antigens of the gametes (sperm and oocytes) have widely been targeted
for prevention of fertilization in a variety of animals. A suite of over 20 sperm
antigens have been identified and characterized, and may ultimately serve as
potential vaccines in some animals. Most of these are surface proteins and
include sperm antigens SP10, SP17, FA-1, LDH-C4, and PH-20 (Delves et al.
2002). However, side effects like autoimmune-mediated orchitis and lack of good
results in contraception, have led to a focus on vaccinating the female with
oocyte antigens.
Fertility levels in vaccinated females are generally reduced from levels of
75% to 80%, to levels of 25 to 30%, in a variety of species including mice (Lea et
al. 2002), baboons (Stevens 1997), and guinea pigs (Tung et al. 1997). Among
the oocyte antigens, a family of surface antigens from the zona pellucida (ZP)
has been identified as providing effective immunocontraception (Meeusen et al.
2007). In 1988, Kirkpatrick et al. (1990) tried a failed human contraceptive called
porcine zona pellucida (PZP) on wild horses on Assateague Island, off the
10

Maryland and Virginia coast in the U.S.. Zona pellucida proteins distilled from pig
ovaries were injected into mares, and these foreign proteins prompted their
immune systems to manufacture antibodies against the antigens. The antibodies
latched onto the surface of newly ovulated mare oocytes, blocking sperm from
entering and fertilizing the egg (Fox 2007). The vaccine was refined so that one
inoculation rendered wild horses infertile for two years (Turner et al. 2007).
SpayVac (Immuno Vaccine Technologies, Canada), a vaccine based on a crude
PZP antigen preparation, has also been available for experimental wildlife
population control.
The most studied and best characterized hormone used as a vaccine
target has been luteinizing-hormone releasing hormone (LHRH), also known as
gonadotropin-releasing hormone (GnRH). GnRH is the key hormone controlling
reproductive function and development and is released from the hypothalamus. It
is a simple 10-amino acid peptide that is found in all species of mammals, with
variants identified in other organisms from lampreys to birds and fish.
Immunoneutralization of this pivotal hormone of the pituitary-gonadal axis has
been demonstrated to prevent reproductive function, provide contraception in
mammals, control estrus behavior in females, and sexual aggression behavior in
males (Meeusen et al. 2007). GonaCon™ is an example of an anti-GnRH
vaccine developed by researchers at the USDA National Wildlife Research
Center (NWRC) (Miller et al. 2004). In a recent (October 2009) and significant
development, GonaCon™ was registered for use in white-tailed deer by the U.S.
11

Environmental Protection Agency (EPA), whose responsibility is to register
products for use in wildlife. GonaCon™ is based on a peptide antigen mollusk
hemocyanin carrier protein conjugate in an oil-based adjuvant (AdjuVacTM). This
formulation has the effect of making the skin of vaccinated animals test positive
for Mycobacterium avium. The vaccine has proved to be effective in species such
as deer (Gionfriddo et al. 2006), bison (Miller et al. 2004), wild horses (Killian et
al. 2006), wild boar (Massei et al. 2008), feral cats (Levy et al. 2004), and
California ground squirrels (Nash et al. 2004).
The goal of this research project study was to field test the vaccine
GonaCon™ in Eastern gray squirrels (EGS). Specific objectives of the project
were the following:
1. To evaluate the efficacy of GonaCon™ in reducing EGS fecundity in urban
areas;
2. To determine appropriate metrics for evaluating the success of
GonaCon™; and
3. To provide recommendations for the use of GonaCon™ as a potential tool
for reducing EGS overabundance in urban areas.
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CHAPTER TWO

FIELD TRIALS OF GONACON™ VACCINE IN
EASTERN GRAY SQUIRRELS

Biology and Ecology of Eastern Gray Squirrels
The Eastern gray squirrel (Sciurus carolinensis; Sciurus, in the shadow of
the tail; carolinensis, first identified in the Carolinas) is a common and prolific
tree-dwelling rodent endemic to urban areas of the eastern United States
(Thompson and Thompson 1980). It is one of several native species of tree
squirrels found in North America (e.g. fox squirrel, S.niger; western gray squirrel,
S. griseus; Abert’s squirrel, S. aberti; Arizona gray squirrel, S. arizonensis;
Mexican fox squirrel, S. nayaritensis; pine squirrel, Tamisciurus hudsonicus; and
Douglas’ squirrel, T. douglasii). The historic range of the Eastern gray squirrel
(referred to in both singular and plural as EGS) was comprised of eastern North
America, until its spread due to numerous introductions. Presently, outside of its
historic range, the species is extant in California, Montana, Oregon, Oklahoma
and Washington in the US. In North America it is also found in Quebec, New
Brunswick, British Columbia, Manitoba, Nova Scotia, Ontario, and Saskatchewan
in Canada (Robinson and Cowan 1954). EGS have also been introduced in Italy,
England, Scotland, and Ireland (Lloyd 1983).
The EGS is a medium-sized tree squirrel that does not display sexual
dimorphism in size or color (Koprowski 1994). Total body length is 380 – 525 mm
and adult body mass ranges from 300 – 710 g (Schwartz and Schwartz 1981).
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The dorsal pelage is dark to pale gray; the fur may be cinnamon colored on the
hips, feet, and head; and the ventral side is white or gray, to buff or cinnamon
(Flyger and Gates 1982). Ears are buff to gray or white, and the long, bushy tail
is white to pale gray and 150 – 250 mm in length (Koprowski 1994). Both
melanism and albinism are common in EGS (Steele and Koprowski 2001). The
only natural sympatric congener of the EGS is the fox squirrel, which is 20%
larger in body mass and brown to black in color (Koprowski 1994).
EGS prefer large tracts of dense, mature hardwoods, especially oaks
(Quercus spp.) and hickories (Carya spp.), with an understory of smaller trees
and shrubs. The fox squirrel, on the other hand, prefers open park-like stands of
pine (Pinus spp.), mixed pine, and oak or oak-gum (Nyssa spp.) -cypress
(Taxodium spp.) stands. Of the two, the EGS is by far the most abundant and it is
numerous enough to manage for recreational hunting purposes (Yarrow and
Yarrow 1999).
EGS feed heavily on nuts, flowers, and buds of nearly 24 oak species, 10
species of hickory and pecan (Carya illinoensis), walnuts (Juglans spp.), and
American beech (Fagus grandifolia) when available (Nixon et al. 1968). Other
important foods include fruits, seeds, buds, or flowers of maples (Acer spp.),
mulberry (Morus spp.), hackberry (Vaccinum spp.), elms (Ulmus spp.), buckeye
and horse chestnuts (Aesculus spp.), wild cherries (Prunus spp.), dogwoods
(Cornus spp.), hawthorn (Crataegus spp.), black gum (Nyssa sylvatica),
hazelnut (Corylus spp.), hop hornbeam (Ostrya virginiana), and gingko (Gingko
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biloba) (Thompson and Thompson 1980). A variety of herbaceous species are
also eaten; fungi are readily consumed in summer. Cultivated crops such as
corn and wheat are also eaten. EGS are known to feed on insects, bones, bird
eggs and nestlings, and frogs (Koprowski 1994). Cannibalism has also been
reported (Holm 1976). Predators of EGS include rat snakes (Elaphe spp.); redtailed (Buteo jamaicensis), red-shouldered (Buteo lineatus), marsh (Circus
cyaneus), and Cooper’s hawks (Accipiter cooperii); great horned (Bubo
virginianus) and barred owls (Strix varia); red (Vulpes vulpes) and gray (Urocyon
cinereoargenteus) foxes; bobcats (Felis rufus); raccoons (Procyon lotor); house
cats (Felis catus), and domestic dogs (Canis lupus familiaris). However, these
predators do not limit EGS population growth in most areas. Since EGS habitat
conditions are constantly in a state of flux, other factors regulate their
reproductive rates. These factors make EGS population densities cyclical.
Whenever an EGS population exceeds the carrying capacity of a forest stand, a
mass movement and relocation of squirrels to other areas may take place. This
exodus may involve thousands of EGS, many of which die during the journey
(Yarrow and Yarrow 1999).
EGS typically have two breeding periods: the first between December and
January, with litters produced between March and April (spring) (Gurnell 1983,
1987). The second breeding period is between May and June, with litters
produced between July and August (summer) (Gurnell 1983, 1987). Female EGS
can become sexually mature at 5.5 months of age (Smith and Barkalow 1967),
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but most do not reproduce until after 1.25 years (Brauer and Dusing 1961).
Gestation period is 44 days (Webley and Johnson 1983) and average litter size is
2 – 3 (Lurz et al. 2002). EGS may have 1, 2, or no litters during a single 10 –
month period (Nixon and McClain 1975). Although males become sexually
mature at 10 to 11 months of age (Kirkpatrick and Hoffman 1960), they undergo
a semiannual cycle of testicular recrudescence and regression. This in turn
impacts their sexual behavior and entire breeding seasons may sometimes be
skipped (Webley et al. 1985). Spring-born males remain sexually active for 6–8
months, while summer-born males are sexually active for about 3 months. Both
groups undergo sexual degeneration in the late summer months (Kirpatrick and
Hoffman 1960). In the wild, EGS rarely live more than 6 years (Uhlig 1955),
although their ecological longevity may be up to 9 years.

Problems Associated with Eastern Gray Squirrels
A tendency for wildlife species to show changes in their behavioral
characteristics and population densities relative to urban areas is termed
“synurbanization” (Parker and Nilon 2008). The EGS is a case in point. For
instance, EGS in parks surrounded by greater levels of urbanization (more
buildings and less trees) will exhibit higher population densities, increased rates
of intraspecific aggression, increased activity levels, and reduced wariness
(Parker and Nilon 2008). Consequently, high EGS densities often increase
conflicts with humans as well as other wildlife.
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The invasiveness and expansion of the EGS has caused problems to
native fauna and humans in its extended range (Lurz et al. 2002, Lever 1994).
Damage and death of hardwood trees by EGS, through bark stripping and
gnawing, might be a result of territorial marking or agonistic gnawing behavior
(Kenward and Parish 1986), and possibly also due to their high densities
(Koprowski 2005). Densities of EGS are normally <3/ha in continuous woodlands
(Barkalow et al. 1970), while EGS densities in small (<10 ha) woodlots can be
16/ha (Doebel and McGinnes 1974), and in urban parks can be > 21/ha (Manski
et al. 1981).
EGS also impact the production of cash and orchard crops like walnuts,
cherries, and pears, since they prefer to eat the nuts and fruits of these trees, as
well as cache them. EGS are prone to travel power lines and short-out electrical
transformers in urban areas causing power outages. They are known to enter
buildings and houses, gnawing on electrical wires which increase the risks of
fires, and build nests in attics destroying attic insulation. Other problems
associated with high EGS densities include destruction of lawns associated with
caching behavior; consumption of bird feeder food and damage to bird feeders;
enlargement of bird house openings; predation on nestling songbirds; and
damage to ornamental plants, planted seedlings, and fruits of planted shrubs and
trees (Hygnstorm et al. 1994).
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Current Techniques to Reduce Conflicts with Eastern Gray Squirrels

Exclusion
Exclusion involves keeping problem EGS out of an area using physical
barriers. Examples may include woven wire fences, electric fences, or any other
barrier that prevents entry or access into an area that needs protection
(Hygnstrom et al. 1994). EGS can be prevented from climbing isolated trees and
power poles by encircling them with a metal collar 1.8 m off the ground (Jackson
1994). Where EGS are entering buildings, a squirrel excluder can be improvised
by mounting a 46-cm section of 10-cm plastic pipe over an opening (Jackson
1994). A one-way door can also be used over an opening to let squirrels out and
prevent them from returning. Openings to buildings can also be closed using
heavy 1.3-cm wire mesh. Custom-designed wire mesh fences topped with
electrified wires have been effective in keeping EGS out of gardens or small
orchards.

Habitat Modification
Habitat modification as a means of reducing EGS damage involves
removing habitat components (e.g. food, shelter, or water) to make areas less
desirable for EGS (Hygnstrom et al. 1994). Limbs and trees can be trimmed 1.8
to 2.4 m away from buildings to prevent EGS from jumping on to roofs (Jackson
1994). EGS can be kept away from bird feeders by tying an ear of corn away
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from where they are causing problems. In some cases, agricultural producers
have cleared trees near orchards to limit incursion and damage of orchard trees.

Repellents
A variety of repellents have been used to keep EGS away from protected
areas. Repellents work by creating an aversion response based on taste, touch
or smell (Hygnstrom et al. 1994). Ropel® is a taste repellent for EGS that can be
applied to seeds, bulbs, and flowers; trees and shrubs; poles and fences; siding
and outdoor furniture (Jackson 1994). Capsaicin is also a taste repellent,
registered for use on maple sap collecting equipment. Polybutenes are sticky
materials that can be applied to buildings, railings, downspouts, and other areas
to keep EGS from climbing.

Trapping
Trapping can either be categorized as capturing live EGS or utilizing lethal
traps that kill EGS. Live-trapping involves removing problem EGS by trapping
and relocating to areas where conflicts are less unlikely to occur. A variety of
traps can be used to catch EGS, including No. 0 or No. 1 leg hold traps, box
traps, and cage traps (Jackson 1994). Glue boards, that are used to capture rats,
have also been used to catch small EGS. Since EGS are classified as game
species in most states, trapping permits may be required from state wildlife
agencies to trap and release problem EGS. The South Carolina Department of
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Natural Resources does not permit the trapping, translocation and releasing of
EGS because of the stress placed on transported and released EGS, as well as
potential impacts on resident EGS populations and concerns regarding the
transmission of diseases. Snap traps used for rats can be used as lethal traps
for small EGS. Effective baits to attract EGS to traps are slices of orange and
apple, walnuts or pecans removed from the shell, and peanut butter (Jackson
1994). Other foods familiar to the EGS may also work well, such as corn or
sunflower seeds.

Shooting
Where firearms are permitted, shooting is an effective control method to
reduce EGS populations and associated problems. A shotgun with No. 6 shot or
a .22-caliber rifle is suitable. However, state wildlife agency regulations and local
ordinances need to be met, as well as the social acceptability of shooting EGS.

Other Methods
Often several control methods used simultaneously are more successful
at reducing EGS conflicts than a single technique (Jackson 1994). For example,
to remove EGS from an attic, they should be observed to determine their entry
and exit portal. After this a combination of repellents and lights may be used to
drive them out, followed by closing entry openings. Baited traps can also be
used to capture any EGS that may have been accidentally closed in with
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exclusion. This last step is important since “locked-in” EGS may cause damage
when they try to chew their way out. Regardless of the technique(s) used, EGS
damage in yards, gardens, forests, and orchards is often very difficult to control.

Immunocontraceptives and GonaCon™
Before the advent of GonaCon™, traditional immunocontraceptive
research was restricted to the use of a vaccine made from zona pellucida
extracted from the ovaries of pigs (Sus scrofa) and named porcine zona pellucida
(PZP) (Miller et al. 1999). GonaCon™ is an immunocontraceptive vaccine that
induces the immune system to generate antibodies to native (“self”) gonadotropin
releasing hormone (GnRH). This is accomplished by conjugating GnRH to a
foreign protein. Because the animal’s immune system has not been previously
exposed to the foreign protein, it generates antibodies to both the foreign protein
and to GnRH. The hypothalamus releases GnRH which then travels to the
anterior pituitary, stimulating the release of leuteinizing hormone (LH), and to a
lesser extent, follicle stimulating hormone (FSH). These two hormones then
trigger the release of testosterone, estradiol, and progesterone from the testes or
ovaries. Testosterone is necessary for breeding behavior and the production of
sperm. Estradiol plays a crucial role in egg development and quality; whereas,
progesterone is needed for ovulation and maintenance of pregnancy. Antibodies
bind native GnRH as it leaves the hypothalamus, thus preventing it from binding
to receptors in the anterior pituitary. As a result, no LH and little FSH is released
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from the pituitary. Without the stimulus of LH and FSH, the testes and ovaries do
not produce testosterone, progesterone, and produce little estradiol. Therefore
no sperm or eggs are produced. Developed as a single-shot vaccine,
GonaCon™ has been proven has been proven efficacious for ≥ 2 years in many
pest species including white-tailed deer, domestic and feral pigs, bison, wild
horses, cats and dogs (Miller et al. 2004). The GnRH immunocontraceptive
vaccine has been successfully used on rats (Rattus norvegicus) and California
ground squirrels (Spermophilus beecheyi) (Miller et al. 1997, Nash et al. 2004).
Using only a single shot, its effects typically last ≥ 2 years which means it could
render a rodent, like EGS, permanently infertile due to the short life span of
rodents. There is no danger to non-targets since the vaccine is injected directly
into the target animal. The vaccine consists of proteins; therefore, a secondary
consumer is unlikely to be contracepted as proteins are broken down in the
stomach. Although research continues on the development of an oral
GonaCon™ immunocontraceptive, animals must currently be captured and
injected by hand with a GonaCon™ vaccine.
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Objectives and Methods

The purpose of this study was to field test the immunocontraceptive
GonaCon™ as a potential vaccine to prevent reproduction in EGS in urban
areas. Objectives of the study were the following:
1. To evaluate the efficacy of GonaCon™ in reducing EGS fecundity on the
campus of Clemson University,
2. To evaluate the use and appropriateness of various metrics in determining
the effectiveness of GonaCon™ in reducing EGS fecundity, and
3. To evaluate the use of GonaCon™ as a potential tool to reduce EGS
overabundance in urban areas and provide recommendations for further
research.

Study Area
Field trials examining the effects of GonaCon™ on EGS were conducted
on Clemson University’s (CU) main campus from March 2008 to June 2009. The
CU campus, located in northwestern South Carolina, is composed of
approximately 325 ha of teaching, research and administrative buildings
interspersed with about 6600 trees (primarily oak, Quercus spp.; and hickory,
Carya spp.), in addition to landscaping shrubs and bushes. Past estimates of
EGS densities on CU’s campus were higher (4.7 EGS/ha) than what has been
reported in nonurban wooded habitats (0.6-3.8 EGS/ha) (Hein 1997). CU’s
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landscaping crew has documented over 100 mature trees killed, and an
additional 100 trees severely damaged on CU’s main campus by EGS for an
estimated $ 1.3 million in damage (Carson, pers. comm.).
The study area consisted of 5.67 ha on CU’s main campus (Figure 1), and
was selected based on the following criteria:
•

A visible overabundance of EGS,

•

Ease of access to study animals, and

•

Proximity to project research facilities at CU.

Eastern Gray Squirrel Trapping
EGS were captured on a 5.67 ha study site on Clemson University’s main
campus during four trapping sessions (TS1 = March – April 2008, TS2 = July
2008, TS3 = November 2008, and TS4 = May – June 2008) using a modified
wooden box trap design (Mosby 1955). Forty wooden box traps (Table 1) were
baited with a mixture of corn and oiled sunflower seeds during each of the four
trapping sessions. The trap design (Mosby 1955) allowed a welded-mesh funnel
and collar to be securely fastened to the front end of the trap. A slotted nylon
capture cone made was tied on to the collar to facilitate EGS handling (Figure 2).
A total of 317 EGS (117 originals and 200 recaptures) were captured
during the study. EGS were handled using the restraint cone and sexed,
weighed, ear-tagged and implanted with a numbered microchip directly under the
skin on the nape of all “originals”, and then later identified as “recaptures” during
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subsequent trapping sessions. EGS were vaccinated with GonaCon™ before the
onset of their breeding season so they could be potentially contracepted before
breeding began. On trapping, each EGS received either GonaCon™ or a sham
control on the basis of toss of a coin for a randomized treatment design. The first
trapping session (TS1) was conducted during March – April 2008 and 33 EGS
were administered GonaCon™ and 22 a sham control. The ensuing breeding
season of May – June 2008 was missed and the second trapping session (TS2)
was conducted in July 2008. The third trapping session (TS3) was conducted in
November 2008. The last session (TS4) corresponded with the May – June EGS
breeding season. Thirty five EGS captured during TS4 were euthanized and
necropsied for histological assessments.
Traps were set at dawn and remained open until dusk. Traps were
checked at one hour intervals and all trapped EGS were processed in a timely
manner (mean handling time = 10 minutes) and released at the trap site.
Captured EGS normally moved into the restraining cone once the trap door was
opened. If not, handlers used noise or aerosol cans of compressed air to move
EGS into the cone. The cone worked well as a restraint device and EGS were
easily handled, examined, treated and released.

Morphometric Data from Study Animals
EGS were sexed based on their external genitalia and presence of
mammary glands. Lactation in females was assessed, as well as scrotal
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pigmentation and testicular development in breeding males, as indicators of
potential fertility. Presence or absence of lactation was determined by
appearance of teats and milk secretions. Females were determined to be
lactating if they had swollen teats with little or no hair covering them. Pigmented
teats indicated that females had pups in the past. Testicular development was
assessed on the basis of size in mm. Length and width of both control and
treated EGS male scrotums were measured with digital calipers and scrotal size
was used to assess age classes, in addition to being a potential metric for
evaluating the effect of the vaccine. Furthermore, males were considered to be
breeding if they had a gray or black pigmented scrotum with little hair covering
the scrotum as well as enlarged testes. Males were considered to be nonbreeding if they had a pink pigmented scrotum with hair regrowth evident and
small flaccid testes (Pudney 1976, Webley et al. 1985, Ferryman et al. 2006).
A combination of pelage characteristics and body weights were used to
assign an age class to individuals (Dimmick and Pelton 1996). Although scrotal
pigmentation can be used in aging male EGS, the appearance of sub-adult and
adult males with regressed testes can often be confusing (Hoffman and
Kirkpatrick 1959). Skeletal and tooth characteristics, as well as dry weight of eye
lens has been used to estimate EGS age, but these methods require euthanizing
the animal. EGS age classes for the purpose of this study were defined as the
following: juvenile: 0 – 6 months of age; sub-adult: 6 – 12 months of age; and
adult: > 12 months of age.
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All “original” and “recaptured” EGS were weighed using a digital weighing
scale (Slater 1kg scale). The null hypothesis that body weights would not differ
between treated and control EGS was tested.

Identification of Study Animals
EGS were ear-tagged for easy recognition. Self-piercing and uniquely
numbered ear tags (Model 1005-1, National Band and Tag, Newport, KY) were
applied with tag-pliers at the thickest part of the cartilage in the pinna of both
ears. Ear-tag color codes used for identifications were the following;
red = control female, white = treated female, yellow = control male, and blue =
treated male.
Passive Integrated Transponder (PIT) microchip tags were inserted under
the skin at the nape to serve as a second identifier in the event that ear tags
were inadvertently pulled or fell out of EGS ears. Prior to insertion PIT tags, were
scanned to verify that they worked and to record the number on data sheets
(Table 3). The dorsal skin between the scapulas was pinched to form a “tent” and
pit tags were delivered subcutaneously using a syringe and insertion needle. As
the needle was withdrawn, the injection site was pinched off to ensure that the
PIT tag would not fall out. EGS were then scanned to verify that PIT tags
remained functional.
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Estimation of Eastern Gray Squirrel Densities
Pooled capture-mark-recapture data were used to estimate EGS densities
for each trapping session on the study site using the Lincoln-Peterson method
(Gerhardt 2005). The sampling design for the basic capture–recapture model for
estimating the size of a closed population involves randomly capturing EGS (n0)
from the population, tagging and releasing them, and later capturing a second
EGS sample of size (n1) and looking at the number of tagged EGS (m1) in the
second sample. The Lincoln–Peterson model was used to express the equation
NLP = (n1xn2)/m2. The assumption of a closed population in this density estimation
was likely not violated, because EGS in this study had a high site fidelity based
on high recapture rate in each of the trapping sessions.

Formulation of GonaCon™
The GnRH vaccine construct was developed by the USDA National
Wildlife Research Center (NWRC) in Fort Collins, Colorado. The 10-amino acid
GnRH peptide hormone was made immunogenic by coupling the peptide to a
mollusk hemocyanin. The GnRH used in this study was synthesized at
Macromolecular Resources, Colorado State University (Fort Collins, CO,) with
the structure [pEHWSYGLRPGGC-SH]. The underlined amino acids represent the
native GnRH molecule. A glycine was added at the C terminus as a spacer, and
a cysteine was added to ensure consistent alignment of the peptide to the
maleamide-activated mollusk protein. The aqueous-based GnRH conjugate was
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combined in a 1:1 ratio by volume with a novel adjuvant (AdjuVac™), which is an
oil-based adjuvant containing small quantities of killed Mycobacterium avium.
GonaCon™ is supplied in refrigerated, 3ml, pre-loaded syringes (NWRC SOP BT
016.02).

GonaCon™ Treatment of Eastern Gray Squirrels
GonaCon™ was given by injection to 33 (17m, 16f), 23 (14m, 9f) and 11
(8m, 3f) EGS at a dosage rate of 0.4 ml containing 400 µg of GnRH-blue protein
conjugate intramuscularly in the thigh during three trapping sessions (TS1, TS2,
TS3). A sham injection containing 0.4 ml saline- AdjuVac™ was administered to
22 (16m, 6f), 20 (12m, 8f) and 8 (4m, 4f) control EGS during the same three
sessions (NWRC SOP BT 004.01). EGS were randomized by the toss of a coin
to receive either a GonaCon™ or a sham injection.

Methodology for Collecting and Processing Blood
A method of collecting blood from laboratory mice was modified for EGS
(Hoff 2000). The saphenous vein, found on the caudal surface of the thigh,
served as the site of veinpuncture and blood collection from EGS. After hair was
removed from the area with the aid of clippers, the skin over the vein was
prepped with isopropyl alcohol. The vein was then punctured using a 20 gauge
needle and drops of blood were collected in serum separation tubes. Bleeding
was then stopped by applying pressure. EGS blood samples were centrifuged to
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separate serum and serum was stored in a freezer (-20. C) until assayed for
steroid hormones and antibodies (NWRC SOP FP 030.00)

Scrotal Size Measurements
The length and width of scrotums were measured with digital calipers in
both treated and control EGS males for the 3 trapping sessions (Table 4). The
null hypothesis that scrotal size would not differ between treated and control
males was tested.

Determination of Progesterone and Testosterone Concentrations
Radioimmunoassay (RIA) on EGS sera samples from treated and control
females, and treated and control males, was performed to measure the
progesterone and testosterone concentrations, respectively (NWRC SOP BT
025.00). The assays were performed using Coat-A-CountTM kits from Diagnostic
Products Corporation (Los Angeles, CA). Repeat samples from EGS captured
over at least two trapping sessions were used for assays to compare hormonal
levels over time. For progesterone assays, treated females (n = 12) and control
females (n = 7) were assessed for changes in progesterone concentrations
(Table 6). Similarly, treated males (n = 7) and control males (n=7) were assessed
for changes in testosterone concentrations (Table 5). The null hypothesis that
testosterone concentrations would not differ between treated and control males
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was tested. Similarly, the null hypothesis that progesterone concentrations would
not differ between treated and control females was tested.

Detection of GnRH Antibodies
In order to detect GnRH antibodies from study animals over time, repeat
samples from EGS captured over at least two trapping sessions were tested to
detect antibodies to GonaCon™. Enzyme-linked immunosorbent assay (ELISA)
on sera samples from treated females (n = 5) and control females (n = 4), and
treated males (n = 6) and control males (n = 4) were performed (Table 7) (NWRC
SOP BT 017.00). The ELISA assessed the immune response of EGS to the
GnRH vaccine by detecting GnRH antibodies in EGS serum. Anti-rabbit IgG
labeled with horseradish peroxidase was used to detect the quantity of bound
antibody. The null hypothesis that antibody titers would not differ between treated
and control EGS was tested.

Statistical Analysis
Descriptive statistics (mean ± S.E.) were calculated for continuous
variables. Proportions or ratios were calculated for categorical variables in each
group. Continuous variable means were compared over time between treatments
and controls (testosterone and progesterone concentrations, scrotal size) using
one-way repeated measures analysis of variance (ANOVA) followed by the pair
wise t –test and trend analysis to generate graphs. Level of significance was set
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at 0.05. Categorical variables (GnRH antibody titers) were compared over time
and between treatments and controls using Fisher’s exact test of proportions. All
statistical calculations were performed using Proc GLM and Proc frequency of
SAS.

Results
Eighty nine EGS were trapped on the 5.65 ha study site on CU’s main
campus from March-April 2008 (TS1: first trapping session). During July 2008
(TS2: second trapping session) 114 EGS were trapped, and in November 2008
(TS3: third trapping session) 79 EGS were trapped. During May-June 2009 (TS4:
fourth trapping session) 35 EGS were trapped for necropsy examination. A total
of 317 EGS were captured during the study (Table 1 and 2).

Eastern Gray Squirrel Densities
The Lincoln–Peterson model (NLP = (n1xn2)/m2 ) was used to estimate
ESG numbers on the study site where:
NLP = EGS population estimate;
n1 = Number of EGS originally trapped, tagged, and released;
n2 = Number of EGS trapped subsequently with and without tags;
m2 = Number of EGS trapped subsequently with original tags.
For TS1, NLP = (65x42)/45 = 80 EGS on the study site, and density
(D) = 80/5.67 ha ≈ 14 EGS/ha
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For TS2, NLP = (43x73)/71 = 49 EGS on the study site, and density
(D) = 49/5.67 ha ≈

9 EGS/ha

For TS2, NLP = (19x64)/60 = 20 EGS on the study site, and density
(D) = 20/5.67 ha ≈

4 EGS/ha

Mean (D) = 9 ± (2.89)

Body Weight Measurements
Body weight measurements were obtained from 33, 23, and 11 treated
EGS; and 32, 20, and 8 control EGS over 3 trapping sessions (TS1, TS2, TS3),
respectively. During TS1 the mean body weights (± SE) for treated and control
EGS were 463.94 ± 12.37 and 455.31 ± 12.49 grams, respectively across all age
classes and both sexes. These means were not significantly different (t = - 0.49,
df = 63, p = 0.63). During TS2 mean body weights for treated and control EGS
were 453.91± 16.46 and 448.00 ± 16.60 grams, respectively. These means were
not significantly different (t = - 0.25, df = 40, p = 0.80). During TS3 the mean body
weights for treated and control EGS were 451.00 ± 25.74 and 419.00 ± 27.22
grams, respectively. These means were not significantly different (t = - 0.86, df =
16, p = 0.40). Pooled data for control and treated EGS was used in the analysis
above (Figure 9) since there is no sexual dimorphism in size.
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Scrotal Size Measurements
Twenty one scrotal size measurements (length x breadth) collected over 3
trapping sessions (TS2, TS3, TS4) from 7 control and 7 treated EGS males were
tested for differences. Scrotal size measurements were compared between
treated and control males within each session and across all three sessions as
well.
During TS2 mean scrotal size for treated males was 110.99 ± 96.68 mm
and for control males 118.63 ± 127.39 mm. However, these means were not
significantly different (t= 0.08, df = 8, p = 0.93).
During TS3 mean scrotal size for treated males was 45.61 ± 76.76 mm
and for control males 109.16 ± 133.02 mm. However, these means were not
significantly different (t= 76.76, df = 8, p = 0.56).
During TS4 mean scrotal size for treated males was 141.46 ± 76.76 mm
and for control males 1101.75 ± 108.63 mm. These means were significantly
different (t= 10.14, df = 8, p = 0.001) indicating a significant difference in scrotal
size of treated and control EGS with a reduction in scrotal size being observed in
treated males (Figure 10).

Hormone Concentrations
Testosterone Assays
Thirty three serum samples were collected over 3 trapping sessions (TS1,
TS2, TS3) from 7 control and 7 treated EGS and analyzed using RIA. During
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TS1, the mean testosterone concentration for treated males was 0.33 ± 0.14
ng/ml and for control males 0.34 ± 0.15 ng/ml. However, these means were not
significantly different (t= 0.04, df = 15, p = 0.96).
During TS2, mean testosterone concentration for treated EGS males was
0.34 ± 0.13 ng/ml and for control males 0.28 ± 0.12 ng/ml. However, these
means were not significantly different (t= -0.32, df = 15, p = 0.74). During TS3,
mean testosterone concentration for treated EGS males was 0.45 ± 0.09 ng/ml
and for control males 0.62 ± 0.13 ng/ml. However, these means were not
significantly different (t= 1.02, df = 15, p = 0.32) There were no differences
between testosterone concentrations of treated and control EGS by the third
trapping session (Figure 11).

Progesterone Assays
Thirty serum samples were collected over 3 trapping sessions (TS1, TS2,
TS3) from 12 treated and 7 control EGS females and analyzed using RIA. During
TS1, mean progesterone concentration for treated females was 1.67 ± 0.93
ng/ml and for control females 1.26 ± 1.19 ng/ml. However, these means were not
significantly different (t= - 0.29, df = 8, p = 0.78).
During TS2, mean progesterone concentration for treated females was
0.93 ± 1.69 ng/ml and for control females 1.86 ± 1.31 ng/ml. However, these
means were not significantly different (t= 0.43, df = 8, p = 0.68). During TS3,
mean progesterone concentration for control females was 4.64 ± 1.13 ng/ml.
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There were no significant differences between the progesterone
concentrations of treated and control EGS females by the third trapping
session (Figure 12).

Antibody Titers
Seventy serum samples were collected over 3 trapping sessions (TS1,
TS2, TS3) from 9 control and 7 treated EGS females, and 9 control and 7 treated
EGS males. Samples were analyzed for the presence of active antibodies to
GnRH using ELISA.
During TS1, the ratio of treated EGS with active antibodies was 1:8 and
the ratio of control EGS with active antibodies was 0:11. These ratios were not
significantly different (χ2 = 1.286, df = 1, p = 0.256). During TS2, the ratio of
treated EGS with active antibodies was 2:7 and the ratio of control EGS with
active antibodies was 12:6. These ratios were significantly different (χ2 = 4.747,
df = 1, p = 0.029). During TS3, the ratio of treated EGS with active antibodies
was 0:5 and the ratio of control EGS with active antibodies was 7:4. These ratios
were significantly different (χ2 = 5.656, df = 1, p = 0.017).
ELISA showed significant differences between the antibody titers of
treated and control EGS by the third session (Figure 13). However, 5 control
animals, 3 females and 2 males, showed high antibody titer.

36

Injection Site Reactions and Mortalities
There were 4 injection site abscesses in treated and 2 in control EGS. The
ratio of injections given to the occurrences of abscesses at the site of injection for
treated EGS was 40:4 and 33:2 for control EGS. These ratios were not
significantly different. (χ2 = 0.3167, df = 1, p = 0.5736) Two EGS died as a result
of trap failure, and 3 animals died as a result of predation injuries, possibly from a
raptor, during the period of study.

Discussion
The results of the controlled efficacy trial demonstrate that peak antibody
titers of 1:12,800 were induced both in male and female EGS by a single
injection of 400 µg of GonaCon™ when tested 2 months post-treatment. This is
consistent with similar responses to GnRH in male cats (Levy et al. 2004), male
dogs (Ladd et al. 1994), female white-tailed deer (Curtis et al. 2007), and female
wild boar (Massei et al. 2008). Five control EGS showed high titer levels likely
due to an inexplicable sampling error. The possibilities include a recording error,
laboratory error, or the inadvertent vaccination of control EGS with GonaCon™.
However, antibody titers are a good metric and an important pointer to the
immunogenic success of GonaCon™ immunocontraception.
Hormonal assays proved to be inconclusive, because there were no
significant differences in either progesterone or testosterone concentrations
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between treated or control EGS. This likely is due to the fact that blood was not
collected from EGS during the peak of breeding seasons.
The blood collection technique used in this study does not seem to be an
appropriate one for hormonal assays that are colorimetric. Evidently, the EGS
blood samples clotted rapidly, and this led to hemolysis when serum was
separated. In the presence of hemolyzed serum, the concentration of a hormone
or antibodies will be lowered and the results thereby affected. Therefore, a better
blood sampling technique needs to be used.
The findings in 14 EGS males (7 treated and 7 control) in TS2, TS3
and TS4) indicated a significant reduction in scrotal size in GonaCon™ treated
males by TS4, as compared to control males. Although there seemed a
substantial difference in scrotal size in TS3 as well, this was not significant likely
due to a small sample size or the large variances observed. The marked
difference seen in TS4 was likely due to sustained vaccine effects that had, in all
likelihood, caused a marked reduction in the scrotal size by TS4. This
corresponds with differences in mean testicular weights of treated and control
EGS on necropsy examination (Table 9). The reduction in scrotal size of treated
males is an indicaton that GonaCon™ possibly caused immunological castration
in male EGS, which is in agreement with an similar response seen in male dogs
and male cats treated with a similar immunocontraceptive vaccine (Ladd et al.
1994, Levy 2004).
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GonaCon™ did meet an important criterion of an ideal contraceptive
vaccine, as it did not cause any significant differences in body weights between
treated and control EGS. However, the vaccine did cause injection site reactions
in 6 EGS as seen in other studies (Miller et al. 2008; Tizard 2009). This problem
can likely be overcome when an improved vaccine formulation is designed by the
manufacturer.
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CHAPTER 3

HISTOLOGICAL CHANGES IN THE GONADS OF EASTERN GRAY
SQUIRRELS VACCINATED WITH THE IMMUNOCONTRACEPTIVE
GONACON™

Introduction
There have been occasional reports of adverse effects of vaccines in
animals. Although often mild, these effects have included allergic reactions and
the development of sarcomas in cats (Tizard 2009). The absence of harmful
side effects is one important attribute of an ideal contraceptive. However, some
studies have documented pathological impacts on the reproductive tract with the
use of both immunocontraceptive vaccines and hormonal contraceptives. The
Porcine vaccine zona pellucida (PZP) resulted in ovarian lesions in white-tailed
deer (Curtis et al. 2007). Endomterial hyperplasia, hydrometra and uterine
infections have occurred in melengestrol acetate (MGA) treated ungulates
(Munson 2005).
GonaCon™ primarily blocks the entry of GnRH into the hypophsis of the
pituitary gland, and thereby suppresses steroidogenesis, oogenesis, and
spermatogenesis (Robbins 2004). The gonads are an important source of the
sex hormones – testosterone in the male, and estrogen and progesterone in the
female. It is probable that reversible or irreversible histological changes occur in
the testes and ovaries as a result of GonaCon™ vaccination. A GnRH-KLH
vaccine similar to GonaCon™ caused testicular atrophy in cats (Levy et al.
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2004). However, testicular atrophy may be a desired effect as long as it does
not negatively impact the health of the animal.
Histological changes in the testes and ovaries of 35 EGS were evaluated
as metrics of effectiveness for GonaCon™ in EGS. Detailed necropsies of EGS
were conducted to assess ovarian and testicular abnormalities, or other potential
health concerns resulting from the vaccination (Table 1 and 2). Objectives of this
study were the following:
1. To evaluate histological changes in testes and ovaries as a metric to
determine the effectiveness of GonaCon™ in reducing EGS fecundity, and
2. To determine any potential side effects in EGS treated with either the
GonaCon™ vaccine or sham control injections.

Materials and Methods
Reproductive Anatomy of Male Eastern Gray Squirrels
In adult EGS males, the testes lie in scrotal sacs on either side of the
penis. The prostate is a single, elongated, compact gland located in the proximity
of the urinary bladder and attached to the muscular part of the urethra (Allanson
1933). The seminal vesicles are small and adhere closely to the prostate. A pair
of large spirally wound Cowper’s glands are located at the sides of the rectum
and lie embedded in the fascia of the thigh. A long thick duct passes from each to
open into the bulb of the urethra. The penis is sharply bent backwards at its distal
end. In sub-adult and juvenile male EGS, the testes lie subcutaneously on each
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side of the penis. The accessory glands are small and the seminal vesicles and
Cowper’s glands are difficult to distinguish (Allanson 1933).

Reproductive Anatomy of Female Eastern Gray Squirrels
The female EGS has a duplex uterus with two cervices, no uterine body,
and horns completely separated (Deanesley and Parkes 1933). The uterus is
large and contains multiparous arteriopathies in the endometrium in the parous
female. In the prepubertal female, the flattened cornua are small and threadlike.
Externally, the surface of ovaries is similar for both prepubertal and parous
females; however, the ovarian mass is greater in parous females (Nixon and
McClain 1975). Internally, the ovaries of the EGS resemble those of Norway
rats (Rattus norvegicus) or house mice (Mus musculus), with comparatively little
interstitial tissue (Deanesley and Parkes 1933).

Study Area
Experimental field trials of GonaCon™ were conducted on Clemson
University’s (CU) main campus located in northwestern South Carolina. The
campus is approximately 325 ha of teaching, research and administrative
buildings interspersed with about 6600 trees (primarily oaks Quercus spp., and
hickories Carya spp.), in addition shrubs and bushes used for landscaping.
Densities of EGS are normally <3 EGS/ha (Barkalow et al. 1970). Using LincolnPeterson model, EGS density was estimated to be 9 EGS/ha on the study area.
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Vaccine Formulation
Both male and female EGS were vaccinated with either GonaCon™
(treatment) or a sham-injection (control) prepared and supplied by the USDA
National Wildlife Research Center (NWRC, Fort Collins, CO). Treated EGS were
injected with 0.4 ml of GonaCon™ which contained 1000 micrograms GnRH-blue
protein conjugate per ml; therefore, each 0.4 ml dose contained 400 µg GnRHblue conjugate. Control EGS were injected with 0.4 ml saline-Adjuvac
intramuscularly in the thigh.

Vaccination Protocol
Using a modified wooden box trap design (Mosby 1955), 99 EGS were
captured from March-April 2008 (first trapping session = TS1). During July 2008
(second trapping session = TS2), 114 EGS were captured, and in November
2008 (third trapping season = TS3) 80 EGS were captured on the study. EGS
were handled using a restraint cone, sexed, weighed, ear-tagged, and implanted
with a microchip under the skin in the nape of all “originals” and read as
“recaptures” on subsequent trapping.
Vaccination with GonaCon™ or sham-controls was conducted by
intramuscular injection in the thigh of both male and female EGS. GonaCon™
was administered to 33, 23 and 11 EGS during the three respective trapping
sessions (TS1, TS2, and TS3). EGS were released at the site of capture after
treatment. Sham injections were administered intramuscularly in the thigh to 22,
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20 and 8 EGS during the same three trapping sessions as treated EGS. EGS
were randomized by the toss of a coin to receive either a GonaCon™ or a sham
injection.

Eastern Gray Squirrel Necropsies
In April and May of 2009, 35 EGS were humanely euthanized by an
overdose of halothane anesthesia (CU RS/SOP 300-04-02). Necropsy
examinations were performed on all 35 EGS; 18 males (8 treated 10 control) and
17 females (8 treated 9 control) (Table 9 and 10). All necropsies were performed
within 10 minutes after EGS were euthanized. Gross examinations and
measurements included body weights, body condition, internal organs, weights of
testes and ovaries, examination of injection sites, and documentation of any
visible abnormalities. Ovaries, uteri and mammary glands were collected from
females and fixed in 10% neutral buffered formalin (NBF) (Gugic et al. 2007).
Testes and prostate glands were collected from males and fixed in modified
Davidson’s fluid (Latendresse et al. 2002). The pituitary gland was collected
from both sexes and fixed in 10% NBF. Histological examination was conducted
after tissues were embedded in paraffin, and stained with hematoxylin-eosin
(Allanson 1933). Prepared histological slides were interpreted by a veterinary
pathologist using an optical microscope (Nikon A2100 microscope equipped with
DS-Ri1 color camera).
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Terms of Reference
Seminiferous tubules in the testes are the specific site for the process of
cellular differentiation to generate mature spermatozoa. Each testis contains
many seminiferous tubules, which are connected at both ends to a collecting
system called the rete testis. A degeneration of seminiferous tubules will disrupt
the process of sperm production leading to infertility (Ogawa et al. 1997).
Sertoli cells or nurse cells line the seminiferous tubules and nurture
spermatogenesis. The relationship between germ cells and Sertoli cells is
important and obligatory (Griswold 1995). Evidence of cavity formation in the
Sertoli cells with resultant shedding of immature sperm cells is termed
vacuolation (Hild et al. 2001).
The interstitial cells (Leydig cells) in the testes secrete testosterone, are
rich in lipid droplets, and have a cord-like arrangement. These cells provide
spaces that improve cell secretion of hormones and facilitate transport into the
blood (Hafez et al. 1997). In the event of testicular atrophy, a decrease in number
and size of Leydig cells will occur, and testosterone production will be impaired
as a result.

Statistical Analysis
Descriptive statistics (mean ± S.E.) were calculated and normally
distributed data over time (organ weights and diameter) were compared using
one-way repeated measures analysis of variance (ANOVA) using the general
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linear models procedure (Proc GLM) of SAS software (Version 9.1). This was
followed by a pair wise t –test and trend analysis to generate graphs. Level of
significance was set at p = 0.05.

Results
Gross and histological examination were conducted on 8 treated males,
10 control males, 8 treated females, and 9 control female EGS. Mean wet testes
weight of control EGS males was 4010 ± 704.64 mg and 336 ± 61.22 mg for
treated males. There was a significant reduction in testes weights in treated
males (t = 5.19, df = 8.12, p = 0.0008).
The proportion of treated EGS males with degeneration of seminiferous
tubules was 1.0, and the proportion of control males with degeneration of
seminiferous tubules was 0. These proportions were significantly different (χ2 =
18.0, df = 1, p = 0.0001).
The proportion of treated EGS males with atrophy of Leydig cells was 1.0,
and the proportion of control males with atrophy of Leydig cells was 0. These
proportions were significantly different (χ2 = 18.0, df = 1, p = 0.0001).
The proportion of treated EGS males with vacuolation of Sertoli cells was
1.0, and the proportion of control males with vacuolation of Sertoli cells was 0.
These proportions were significantly different (χ2 = 18.0, df = 1, p = 0.0001).
Mean wet weight of ovaries of control EGS females was 103 ± 25.96 mg
and 98 ± 8.61 mg for treated EGS females and were not significantly different (t =
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0.17, df = 9.73, p = 0.86). There were no significant differences in the diameter of
the uterine horns and the length of the tract from the vagina to the ovaries
between control and treated EGS females. There were no pregnancies found in
either control or treated EGS females.
Representative cross sections of testes in control EGS males exhibited
densely packed tubuli seminiferi with intact spermatogenesis (see arrow) and
robust looking interstitial Leydig cells (Figure 3.A) In treated EGS males atrophic
tubuli seminiferi and Leydig cells (see arrow) with degenerating spermatocytes
are seen (Figure 3.B).

Figure 1. Cross-section of testes of control (A) and GonaConTM treated (B) EGS
males (H&E stain, Bar = 90 µm).
Representative cross sections of epididymis in control EGS males
exhibited a lumen filled with abundant mature spermatozoa (see arrow) (Figure
4.A). In treated EGS males lumen devoid of spermatozoa are seen (arrow)
(Figure 4.B).
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Figure 2. Cross-section of epididymis of control (A) and GonaCon™ treated (B)
EGS males (H&E stain, Bar = 90 µm).
Representative cross sections of prostates in control EGS males exhibited
normal glandular epithelium (see arrow) (Figure 5.A). In treated EGS males
contracted dark glandular tissue and evidence of advanced atrophy is seen
(arrow) (Figure 5.B).

Figure 3. Cross-section of prostate of control (A) and GonaCon™ treated (B)
EGS males (H&E stain, Bar = 90 µm).
Representative cross sections of ovaries in control and treated EGS
females did not exhibit any observable differences (Figure 6)
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Figure 4. Cross-section of ovaries of control (A) and GonaCon™ treated (B)
EGS females (H&E stain, Bar = 90 µm).
Representative cross sections of uterus in control and treated EGS
females did not exhibit any observable differences (Figure 7).

Figure 5. Cross-section of uterus of control (A) and GonaConTM treated (B) EGS
females (H&E stain, Bar = 90 µm).
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Representative cross sections of pituitary gland in control and treated
EGS of both sexes did not exhibit any observable differences (Figure 8).

Figure 6. Cross-section of pituitary gland of control (A) and GonaCon™ treated
(B) EGS males. (H&E stain, Bar = 90 µm).
Discussion
The findings in 18 necropsied EGS males (8 treated and 10 control)
indicated a reduction in testes weight (90%) in GonaCon™ treated males, as
compared to control males. There were also marked histological differences in
the testes of treated males, as compared to control males. This suggests that
GonaCon™ treated male EGS were immunoneutered, and exhibited physiologic
traits similar to castrated males. These findings are consistent with studies in
other animals, such as GonaCon™ treated male white-tailed deer, where testes
size was also reduced as a result of anti-GnRH immunocontraception (Curtis et
al. 2008, Pooler 2001, Killian et al. 2006).
Specific histological changes represented in comparisons of 8 treated
EGS males and 10 control males that were necropsied included degeneration of
50

seminiferous tubules, atrophy of Leydig cells and vacuolated Sertoli cells.
Degeneration of seminiferous tubules with concomitant diminished
spermatogenesis observed in treated EGS males in this study, were also
observed in similar studies in Sprague-Dawley rats (Jinshu et al. 2005), whitetailed deer (Curtis et al. 2008), dogs (Ladd et al. 1994), cats (Levy et al. 2004),
and Scottish Suffolk-crossbred rams (Ferro et al. 2004). Atrophy of Leydig cells
and vacuolated Sertoli cells observed in treated male EGS was also seen in male
cats that received anti-GnRH vaccine (Levy et al. 2004).
Male EGS have one unique physiologic attribute that is germane to the
question: whether marked histological changes that were observed in this study
were permanent or transient? It is well documented that male EGS undergo a
semiannual cycle of testicular recrudescence and regression and occasionally
skip entire breeding seasons (Webley et al.1985). Consequently, it is difficult to
preclude the possibility that the histological findings that imply a cessation of
reproduction in GonaCon™ treated male EGS in this study were not due to the
phenomenon of sexual quiescence.
No histological changes in uteri or ovaries were discerned in the 8
GonaCon™ treated EGS females on necropsy. Changes in hormonal levels over
the estrous cycle of EGS results in morphological changes in the ovary, uterus,
and vagina, all of which can be used to determine the stage of cycle (Davis et al.
2001). In other words, no histological changes observed in both GonaCon™
treated and control EGS females in this study could well conform to females that
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were in anestrous or sexual rest, a normal physiologic process in the
reproductive cycles of not only rodents but all mammalian females (Conaway
1971). On the other hand, it could well mean that the treated EGS females were
in senescence. Several factors contribute to the variability in timing of
reproductive senescence in rodents, including the species, environmental
factors, and whether pregnancy actually occurred (Davis et al. 2001).
Even if GonaCon™ is effective only in male EGS, it might still help reduce
or alleviate territorial marking and bark stripping, which seems to be a learned
behavior in male EGS (Kenward and Parish 1986). Consequently, sterilization of
male EGS with GonaCon™ may be a potential tool in preventing destructive
behavior such as gnawing and girdling of trees which causes damage and
economic losses in urban and suburban areas, like Clemson University’s main
campus.
There were no histological changes in the pituitary glands of EGS that
received either GonaCon™ or sham control treatments as evidenced from
necropsy examination of 35 EGS. The pituitary regulates other physiological
processes in EGS, and it is important that these processes are not disrupted or
compromised by GonaCon™. A study of active immunization against GnRH in
pigs caused damage to cells in the hypothalamus other than those producing
GnRH (an action called a by-stander effect) (Molenaar et al. 1993).
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CHAPTER 4
CONCLUSIONS OF FIELD TRIALS OF GONACONTM IN EASTERN GRAY
SQUIRRELS AND RECOMMENDATIONS
Results of this study indicate that a single-dose of 400 µg GonaCon™
vaccine injected in EGS induced GnRH-titer peaks suggestive of an immunologic
response that may have inhibited reproduction in treated male and female EGS
(n = 39:28). Examination of antibody titers, scrotal size, testicular weights;
histological assessment of testes, epididymides, and prostates indicates that
GonaCon™, in all likelihood, was successful in inhibiting breeding in male EGS.
These results imply that GonaCon™, in this study, caused immunocastration in
male EGS.
It is not clear whether GonaCon™ conferred sterility in female EGS in this
study. However, based upon results of antibody titers in female EGS, it is
evident that GonaCon™ was effective at the immunologic level. These results,
however, cannot be extrapolated to imply that breeding was actually inhibited in
female EGS in this study. Breeding behavioral observations of GonaCon™
treated female EGS were not recorded, and examination of potential parturition in
GonaCon™ treated female EGS was not an objective of this study.
It is also important to examine the potential use of GonaCon™ for EGS in
context of the 8 criteria developed by Becker and Katz (1997) for what is
considered an ideal contraceptive agent. These criteria include reversibility,
suitability for remote delivery, effectiveness of a single dose, effects on the food
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chain, harmful side effects, effects on EGS social behavior, costs, and social
acceptability.
Reversibility of immunocontraception restores breeding fitness to the
target species. For some species, like raccoons and EGS, incriminated as pests
in urban and suburban areas, the question of reversibility does not arise.
However immunocastration, due to active immunization against Luteinizing
Hormone-Releasing Hormone (LHRH) in dogs, was found to be reversible and
could be dose dependent (Ladd et al. 1994). Further research is required to
standardize the dosage rate at which GonaCon™ would cause irreversible
infertility in EGS, if that is an objective of affected stakeholders in urban and
suburban communities.
Suitability for remote delivery is an impediment for GonaCon™ use in
EGS, as it can only be delivered at the present time by hand injection.
Consequently, treatment of EGS with GonaCon™ can only be achieved by an
intensive effort to trap EGS, which can be labor intensive, time-consuming, and
costly. The potential difficulty of using GonaCon™ to control EGS reproduction
and populations is compounded in urban and suburban areas, because EGS are
often viewed with affection by a portion of the public, making control efforts
problematic and controversial (Moore et al. 1997). Research at USDA’s National
Wildlife Research Center is currently underway to develop an oral
immunocontraceptive which could be delivered without having to trap and handle
EGS (Miller 1997).
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An alternative to GonaCon™ may be a cholesterol analogue called
DiazaCon™, which inhibits both cholesterol and reproductive hormone
production. DiazaCon™ is delivered as bait by over coating a preferred food
item (e.g. rolled oats for prairie dogs) for a period of 5 to 10 days, and the
contraceptive effects last up to the length of a targeted species breeding season
(Yoder et al. 2007). This product was found to be a potential tool for reducing
fecundity in black-tailed prairie dogs (Cynomys ludovicionus) (Nash et al. 2007)
and monk parakeets (Myiopsitta monachus) (Yoder et al. 2007).
In a recent (October 2009) and significant development in wildlife
contraception, GonaCon™ was licensed by the US Environmental Protection
Agency (EPA) for use in white-tailed deer at a single dose of 1000 µg (Miller,
pers. comm.). It is anticipated that GonaCon™ will also meet the single dose
administration criteria (Becker and Katz 1997) in EGS. Its efficacy as a single
dose administration has proven effective in feral pigs (Massei et al. 2008) and
feral cats (Levy et al. 2004). A long-lasting immune response to GonaCon™
depends on the retained antigen; therefore, a long-term study is required to
determine if and when GnRH antibodies decline in EGS. If long-termed efficacy
is not achieved, then GnRH would not be inhibited resulting in a reversal of
steriodogenesis, spermatogenesis and oogenesis (Robbins et al. 2004).
The manufacturer of GonaCon™, the USDA National Wildlife Research
Center, has determined that there is no danger associated with humans or
wildlife consuming animals treated with GonaCon™. Both GonaCon™, and the
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antibodies produced by an animal treated with GonaCon™, are proteins that
once ingested, are broken down by stomach acids and enzymes. The USDA
Food and Drug Administration (FDA) has also determined that there is little risk
to humans if meat from deer and pigs treated with GonaCon™ was consumed
(Fagerstone et al. 2008).
There were relatively few harmful side effects observed in EGS treated
with GonaCon™ in this study. Of the 117 EGS treated in this study, 67 EGS (39
m, 28f) received GonaCon™ injections and 50 EGS (32m, 18f) the sham control
injections. Six EGS, 4 treated (2 males, 2 females) and 2 controls (both males),
developed injection site granulomas with moderate to severe sterile abscess
formation. Consequently, there was a 7.62% incidence of injection site reactions
in EGS. This was likely due to the water-in-oil emulsion present in the
GonaCon™ formulation (Gupta et al. 1993), or the presence of the bacterium
Mycobaterium avium in the adjuvant, which is necessary for single shot
effectiveness (Perry et al. 2008). Besides the injection site reactions, there were
no other serious side effects to GonaCon™ observed in EGS in this study.
In a separate study, that was conducted in concurrence with this study on
the same study site, the effects of GonaCon™ on the social behavior of EGS
was examined. Eighteen volunteer observers were trained to perform
instantaneous focal sampling of EGS activity budgets over 10-minute sessions.
Over 1150 sessions were recorded and analyzed for differences in EGS activity
budgets between GonaCon™ treated and control EGS. Preliminary results of this
56

study showed that GonaCon™ significantly changed only one behavioral activity
budget of EGS, that being significantly (p = 0.05) more self-grooming by
GonaCon™ treated male EGS, as opposed to control male EGS (Etheredge,
unpublished data). Additional research is needed to more accurately quantify
and describe behavioral activity budgets of GonaCon™ treated and control EGS
over multiple breeding seasons and years.
Economics is also an important consideration when evaluating the
feasibility of wildlife contraception. Costs of GonaCon™ production and delivery,
as well as who pays for these expenses, is an issue of debate (Kirkpatrick 2007).
If GonaCon™ is proven to be effective as a wildlife contraceptive and registered
for use in EGS, it will in all likelihood remain under the strict control and selective
use of USDA Wildlife Services. Although costs of producing GonaCon™ by the
USDA National Wildlife Research Center are not available, costs of delivery can
be estimated based upon the effort involved in trapping and treating EGS in this
study. For example, EGS density on Clemson University’s main campus during
this study was estimated to be 9 EGS/ha. With 567 ha of EGS habitat on
Clemson University’s main campus, the EGS population can be estimated to be
approximately 5,103 squirrels. A previous study on immunocontraception in
rodents concluded that over 90% of the population need to be sterilized to
achieve the desired control (Moore et al. 1997). Based upon this study,
approximately 4593 EGS would need to be treated with GonaCon™ to have an
effect on controlling reproduction and consequently overabundance. Using the
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best trapping success obtained in this study, the same effort to trap 90% of EGS
on Clemson’s campus would take 1000 days at a cost of $ 15/EGS. This
assumes 2.1 hours/EGS to trap and treat with GonaCon™ at an hourly rate of
$7.25/hour (2009 minimum wage). Thus, the labor costs alone for plausible
success of GonaCon™ in control of EGS would be in the region of $ 70,000.
This hypothetical example illustrates the high costs of anti-fertility control
in EGS, which does not include the costs of the vaccine itself. Costs may be
reduced, and effectiveness enhanced, of treating EGS with GonaCon™ if EGS
populations are reduced before initiating a contraceptive program. However, this
integrated approach that includes population reduction, may not be socially
acceptable within urban and suburban communities having high EGS
populations. Other studies that have documented expenses associated with
contraceptive programs concluded it would cost an estimated $25 to $500 to
treat an individual deer, a wild horse, African elephant or even a captive kudu
(Rutberg 2005). Costs of treating EGS with GonaCon™ in urban and suburban
areas would in all likelihood have to be borne by affected individuals,
municipalities and other stakeholders that would benefit from EGS population
control.
Social acceptability of using GonaCon™ to control EGS numbers, as well
as populations of other wildlife species, is another challenge wildlife managers
face. A few animal rights groups maintain that wildlife contraception violates the
reproductive rights of animals (Kirkpatrick 2007). The issue of alteration in
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population genetics due to wildlife immunocontraception may not arise when
small, isolated populations of pest species are concerned (Nettles 1997).
Longer study duration of up to 5 – 6 years, to coincide with the life span of
EGS is critical to provide a frame of reference for year-round hormonal profiles in
both sexes. In addition, a larger sample size of EGS is needed to better
understand the disparity in GonaCon™ effectiveness observed in male and
female EGS in this study. It would take a minimum of one year of continuous
blood sampling in male and female EGS to establish baseline data for hormonal
concentrations over a temporal scale of multiple breeding seasons.
Wildlife contraception remains a contentious issue and the use of antifertility vaccines for population control and reduction of wildlife damage
management has both proponents and opponents. Some proponents are
researchers and those affected by high EGS populations and subsequent
damage in urban and suburban communities, as well as activists who seek nonlethal solutions to human–wildlife conflicts. Some opponents include wildlife
biologists and managers, recreational hunters, and some animal welfare groups
who oppose the use of wildlife contraception (Kirpatrick 2007). Despite the
various perspectives on the use of contraceptives to control growth in wild animal
populations, continued research is needed. Research to evaluate the use of
GonaCon™ and other contraceptives can provide answers to questions that
remain on effectiveness and efficacy, impacts on biology and behavior of target
and non-target species, costs, and social acceptability. A key factor in the
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sustained use of any anti-fertility vaccine is its margin of safety in the target
species. It is important that the vaccine formulation used in this study be
improved to avoid injection site reactions observed in EGS in this study.
Continued research should focus on collecting EGS blood samples of
GonaCon™ treated and control EGS during peak breeding seasons. To
determine the peak of EGS breeding seasons in local populations, baseline
hormonal profiles of EGS are needed through at least one year of breeding
seasons. This is important for future studies, since this study did not detect any
significant differences in hormonal concentrations between GonaCon™ treated
and control EGS. This was likely a result of peak breeding being missed when
blood was collected. Consequently, collection of blood from EGS should
coincide with peaks in breeding, as collection during post-breeding, to enhance
the ability to detect differences in GonaCon™ treated and control EGS. A
definitive method to determine occurrence of potential breeding, as well as
potential parturition in GonaCon™ treated EGS, will provide conclusive evidence
on the efficacy of GonaCon™ as a potential tool for immunocontraception in
EGS.
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Table 1. EGS trapped as “originals”.
March- April
Jul 2008
2008
T
C
T
C
Male
17
16
14
12
Female
16
6
9
8
Total
33
22
23
20

Nov 2008
T
8
3
11

Table 2. EGS trapped as “recaptures”.
March- April
Jul 2008
Nov 2008
2008

C
4
4
8

Total
71
46
117

May- June
2009

T

C

T

C

T

C

T

C

Total

Male

5

7

17

26

18

17

8

10

108

Female

3

19

15

13

5

20

8

9

92

Total

8

26

32

39

23

37

16

19

200
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Table 3. EGS capture data sheet.
RESEARCH DATA
SQUIRREL CONTRACEPTION
RESEARCH PROJECT
Clemson University
Department of Forestry and Natural
Resources
Principal Investigator: Greg K. Yarrow
Phone: 864 – 656 – 5334

Trap#

Sex1

Age2

Weight
(g)

Microchip
Number

Capture, Handling,
Blood Collection and
Vaccination Records

Color
of Ear
Tag
Used3

Breeding
Status

Blood
Collected
(ml)

Project ID: QA-1534
Site:
Date:
Initials:

Vaccine
ID
(Batch#)

Amount
of
Vaccine
given
(ml)

Handling Time5

Start

End

Mt

Scrotal
Size6
(mm)

L

1

F = female, M = male, U = unknown
A = adult, J = juvenile, U = unknown
B = Blue, R = Red, G = Green, W = White
4
LT = lactating, NLT = not lactating, P = pigmented scrotum, NP = not pigmented scrotum, T = descended testes, NT = not
descended testes
5
Time taken in minutes from start of handling to release of animal
6
Scrotal size, length and breadth in mm
*last revised July 2008
2
3

Table 4. Mean scrotal size (mm) measurements of treated and control EGS
males.
Originals

Recaptures

Length (mm)

Breadth (mm)

Length (mm)

Breadth (mm)

Treated Males

20.41 ± 2.5

13.29 ± 1.89

15.07 ± 1.28

9.11 ± 0.95

Control Males

7.11 ± 0.26

5.50 ± 0.45

18.04 ± 2.31

11.73 ±1.76
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B

Table 5. Mean testosterone (nmol/1) concentrations of treated and control EGS
males (B = treated, Y = control).
Color
of Ear
Tag

TESTOSTERONE (ng/ml)

Microchip
Number

Treatment
Status

Breeding
Status

Season 1

Season 2

Season 3

B-132

016-069-087

t

NPT

0.3

.

0.3

M

B-133

016-051-055

t

PT

0.2

0.2

0.2

3

M

B-134

016-076-638

t

NLT

0.2

0.6

1

4

M

B-135

016-086-001

t

NP, NT

.

0.5

0.8

5

M

B-137

016-054-004

t

NPT

0.4

.

0.3

6

M

B-139

016-039-883

t

NP, NT

0.1

.

0.4

7

M

B-191

016-064-337

t

PT

0.8

0.1

0.2

8

M

Y-118

016-095-873

c

PT

0.3

0.4

0.5

9

M

Y-119

016-064-825

c

PT

0.2

0.1

.

10

M

Y-120

016-101-082

c

PT

0.5

0.5

.

11

M

Y-125

019-012-327

c

PT

0.6

.

0.6

12

M

Y-126

016-099-082

c

PT

0.2

.

1.2

13

M

Y-127

019-051-563

c

PT

0.3

0.3

.

14

M

Y-128

016-085-082

c

PT

0.3

0.1

0.2

No

Sex

1

M

2
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Table 6. Mean progesterone concentrations (nmol/1) concentrations of treated
and control EGS females (W = treated, R = control).
PROGESTERONE (ng/ml)

Sex

Color of
Ear Tag

Microchip
Number

Treatment
Status

Breeding
Status

Season 1

Season 2

Season 3

F

W147

016-103-575

t

NLT

2.4

.

.

2

F

W149

016-044-608

t

NLT

1.1

.

.

3

F

W150

016-069-045

t

NLT

.

0.9

.

4

F

W151

016-089-573

t

NLT

2.3

.

.

5

F

W155

016-083-003

t

NLT

1.3

.

.

6

F

W157

016-084-556

t

NLT

1.2

.

.

F

W158

015-844-305

t

NLT

.

0.5

.

F

W160

015-792-356

t

NLT

1.8

.

.

F

W171

016-063-543

t

NLT

1.6

.

.

10

F

W178

019-023-068

t

NLT

1.1

1.4

.

11

F

W179

019-034-110

t

NLT

1.1

.

.

12

F

W180

019-025-256

t

NLT

2.8

.

.

13

F

R-102

016-076-278

c

NLT

1

.

1.6

14

F

R-104

016-088-882

c

NLT

0.9

.

2.1

F

R-106

016-082-602

c

NLT

1.1

1.9

1

F

R-107

016-050-802

c

NLT

2

0.9

.

F

R-111

016-095-798

c

NLT

0.9

3

1.1

18

F

R-114

016-083-358

c

NLT

0.7

0.6

17.4

19

F

R-168

019-036-348

c

NLT

2.2

2.9

.

No
1

7
8
9

15
16
17
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Table 7. Measured antibody titers of treated and control EGS (R = control
female, W = treated female, Y = control male, B = treated male).
MEASURED TITERS
Season
Season Season
1
2
3

No

Sex

1

F

Color of
Ear Tag
R107

2

F

R114

016-095-798

c

NLT

0

0

0

F

R112

NLT

.

0

0

F

019-045-014
019-046-542

c

R49

c

NLT

0

0

0

F

W150

016-069-045

t

NLT

0

128000

.

F

W160

NLT

0

128000

.

7

F

015-792-356
019-010-829

t

W174

t

8

F

W178

9

F

10

3
4
5
6

Microchip
Number

Treatment
Status

Breeding
Status

016-050-802

c

NLT

0

0

.

NLT

0

128000

.

t

NLT

.

128000

.

W82

019-023-068
024-124-828

t

NLT

0

128000

M

Y127

016-085-082

c

NT

0

0

.

M

Y128

NT

.

0

0

12

M

016-099-082
019-032-012

c

Y64

c

NT

.

0

0

13

M

Y66

016-099-082

PT

.

2000

8000

14

M

B132

016-069-087

c
t

NT

0

128000

.

15

M

B133

016-051-055

t

PT

0

128000

.

16

M

B134

016-076-638

t

NT

0

128000

128000

17

M

B137

t

NT

0

.

128000

18

M

B139

016-054-004
016-039-883

t

NT

0

0

64000

B145

016-051-776

t

NPT

0

.

128000

11

19

M
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Table 8. EGS males examined on necropsy (Y = control, B = treated).
Scrotal Size
(mm)
Sex

Color of
Ear Tag

M

B

Testes
Weight
(mg)

20

784.8

18.69

12.4

402.8

PT

30.43

20.61

788.63

016.041-341

NPNT

.

.

238

c

019-045-855

NPNT

.

.

147

490

t

019-064-337

PT

14.84

8.88

512

620

c

016-050-529

PT

24.57

14.83

5767

L

Age

Weight
(grams)

Treatment
Status

Microchip
Number

Y123

A

450

c

.

M

B135

A

610

t

016-086-001

PT

M

Y119

A

550

c

.

M

.

A

550

t

M

Y69

A

480

M

B191

A

M

Y129

A

Status

M

Y125

A

520

c

.

PT

36.54

25

5713

M

Y124

A

470

c

016-097-558

PT

31.55

24.69

4641

M

B139

A

470

t

016-039-883

PT

18.81

11.36

401

M

Y64

A

510

c

019-032-012

PT

35.4

22.48

4134

M

B189

A

430

t

019-068-841

NPNT

.

.

178

M

Y127

A

450

c

019-051-563

PT

34.52

20.45

4130

M

Y117

A

470

c

016-077-309

PT

51.19

29.39

5027

M

B138

A

500

t

015-865-824

PT

10.05

3.18

579

M

B199

A

500

t

019-010-846

NPNT

.

.

266

M

B97

A

430

t

019-035-635

NPNT

.

.

182

M

Y121

A

540

c

.

PT

40.11

28.66

5742

66

Table 9. EGS females examined on necropsy.
Treatment
Status

Microchip
Number

Breeding
Status

Ovaries
weight
(mg)

Diameter
of horn
(mm)

Length
of Tract
(mm)

Sex

Age

Weight
(grams)

F

A

470

t

024-298-825

NLT

97

2

70

F

A

520

c

016-082-602

NLT

110

1.91

90

F

A

590

c

019-036-348

NLT

102

1.51

80

F

A

610

c

019-045-014

NLT

109

1.89

90

F

A

490

c

024-278-118

NLT

19

1.61

50

F

A

430

c

019-062-086

NLT

38

1.44

60

F

A

550

t

016-076-558

NLT

52

1.8

55

F

A

410

c

.

NLT

50

1.71

50

F

A

540

t

024-127-607

NLT

116

2.01

80

F

A

600

c

024-329-607

NLT

112

1.41

90

F

A

480

c

019-042-309

NLT

95

1.1

65

F

A

480

t

019-010-829

NLT

126

2.21

85

F

A

480

t

019-060-865

NLT

102

1.91

65

F

A

430

t

024-124-828

NLT

72

1.14

60

F

A

470

t

016-084-556

NLT

110

2.02

90

F

A

420

t

016-067-085

NLT

108

2

78

F

A

550

c

.

NLT

288

4

85

67

Figure 7. Map of EGS study area.

68

Figure 8. Modified trap design with capture cone

69

Weight (g)

Figure 9. No significant differences in body weights of control and treated EGS in
each trapping session TS1 (p = 0.63), TS2 (p = 0.80), TS3 (p = 0.40).

70

Scrotal Size (mm)
Figure 10. Significant differences in scrotal size of control and treated EGS males
by the fourth trapping session TS4 (p = 0.001).

71

Testosterone nmol/1
Figure 11. No significant differences in testosterone concentrations of control and
treated EGS males by the third trapping session TS3 (p = 0.32).

72

Progesterone nmol/1
Figure 12. No significant differences in progesterone concentrations of control
and treated EGS females by the second trapping session TS2 (p = 0.68).

73

Figure 13. Significant differences in antibody titer activity of control EGS (red)
and treated EGS (blue) by second trapping and third session, TS2 (p = 0.029)
and TS3 (p = 0.017).
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